Detailed price information for Tg Therapeutics (TGTX-Q) from The Globe and Mail including charting and trades.

It would’ve been unfair to expect the 2026 NBA trade deadline to match its predecessor in sheer tonnage of stunnage; “Luka Dončić got traded out of nowhere in the middle of the night” is a pretty ...

Reducing pembrolizumab infusions from 30 minutes to 10 minutes could be a safe alternative for patients and open hundreds of ...

It's not just Botox and IV therapy. The reversal of a COVID rule could upend family and maternal care, mental healthcare ...

Discover tips for managing swelling, redness, and pain at subcutaneous immunoglobulin (SCIg) infusion sites for primary ...

Zoo Knoxville is welcoming a remarkable new resident to the Boyd Family Red Panda Village; a 6-year-old female red panda named Khyana (key-AH-nuh), whose journey is one of resilience, specialized care ...

EDMONTON, ALBERTA, CANADA, January 14, 2026 / EINPresswire.com / — CareMed Wellness Clinic announces the launch of a nurse-led, tiered community care model designed to support individuals across ...

Amid ongoing political, social, and economic uncertainty and tumult, demand for ketamine infusion therapy at the Ketamine ...

Infusion therapies can be "life changing" for those suffering from chronic illnesses, founder Shaya Fogel said.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented (ACTRIMS) annual forum, being held February 5 – ...

LEQEMBI is currently approved in 53 countries and regions and is under regulatory review in 7 countries. In August 2025, the US FDA approved LEQEMBI IQLIK 360 mg for weekly subcutaneous maintenance ...